EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in US Pediatric Unintentional Nonprescription Cold and Cough, Analgesic and Antipyretic Drug Exposure Cases amid the COVID-19 Pandemic

Sara Karami, Christian Angelo I Ventura, Ellen Pinnow, Jody Green, Ajoa Asonye, Ibrahim T Ibrahim, Lynda McCulley, Gerald J Dal Pan, Esther H Zhou

Clinical Drug Investigation · 2025

DOI: 10.1007/s40261-025-01444-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Drug Investigation, 2025. Verfasst von Sara Karami und 8 weiteren Autor:innen. Beteiligte Einrichtung: Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), 10903 New Hampshire A…. Hauptthemen laut MEDLINE: COVID-19, Antipyretics, Analgesics, Common Cold. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oak Ridge Associated Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The coronavirus disease 2019 (COVID-19) pandemic dramatically impacted healthcare systems.

Objective

We assessed monthly unintentional pediatric (< 18 years) exposure case rate trends involving selected nonprescription cold and cough (CC), as well as analgesic and antipyretic (AA) drugs, before and during the COVID-19 pandemic, using the National Poison Data System (extracted August 2023).

Methods

We included dextromethorphan, guaifenesin, phenylephrine, and pseudoephedrine CC drugs, and acetaminophen, naproxen, ibuprofen, and acetylsalicylic acid AA drugs; statins served as a control. We performed descriptive analyses involving single-product unintentional pediatric exposure cases overall, by sex, and by age. We performed interrupted time series (ITS) analyses, modeling associations between the pandemic’s immediate and sustained effects, adjusting for population and seasonality.

Results

Overall, apart from the control, acetylsalicylic acid, and naproxen drugs, monthly unintentional single-product exposure case rates decreased sharply at the pandemic’s onset. In ITS analyses, rates decreased most notably for cases involving children < 6 years old, where unintentional-general and unintentional-therapeutic error case rates statistically significantly fell by 1.8–12.6 cases per million population at the pandemic’s onset. During the pandemic, case rates gradually increased to pre-pandemic levels within 1.5 years. For cases involving children < 6 years old, these exposure case rates statistically significantly rose by 0.1–0.6 cases per million population per month compared with pre-pandemic levels. Monthly case rate patterns for cases 6–12 years old mirrored those of cases < 6 years old, with less pronounced level and trend changes.

Conclusions

These findings underscore the need for continuously adapting public health strategies to ensure drug safety during prolonged periods of public health emergencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AntipyreticsAnalgesicsCommon ColdCoughNonprescription DrugsHumansChildChild, PreschoolMaleFemaleAdolescentUnited StatesInfantSARS-CoV-2Pandemics

Substanzen

AntipyreticsAnalgesicsNonprescription Drugs

Autor:innen und Institutionen

  • Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 22, Room 4202, Silver Spring, MD, 20993, USA.
  • Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 22, Room 4202, Silver Spring, MD, 20993, USA. Esther.Z…

Förderung

  • Oak Ridge Associated Universities

Zitieren

APA

Karami, S., Ventura, C. A. I., Pinnow, E., Green, J., Asonye, A., Ibrahim, I. T., McCulley, L., Dal Pan, G. J., & Zhou, E. H. (2025). Trends in US Pediatric Unintentional Nonprescription Cold and Cough, Analgesic and Antipyretic Drug Exposure Cases amid the COVID-19 Pandemic. Clinical Drug Investigation. https://doi.org/10.1007/s40261-025-01444-9

Vancouver

Karami S, Ventura CAI, Pinnow E, Green J, Asonye A, Ibrahim IT, et al. Trends in US Pediatric Unintentional Nonprescription Cold and Cough, Analgesic and Antipyretic Drug Exposure Cases amid the COVID-19 Pandemic. Clinical Drug Investigation. 2025. doi:10.1007/s40261-025-01444-9

BibTeX
@article{Karami2025,
  author = {Karami, Sara and Ventura, Christian Angelo I and Pinnow, Ellen and Green, Jody and Asonye, Ajoa and Ibrahim, Ibrahim T and McCulley, Lynda and Dal Pan, Gerald J and Zhou, Esther H},
  title = {Trends in US Pediatric Unintentional Nonprescription Cold and Cough, Analgesic and Antipyretic Drug Exposure Cases amid the COVID-19 Pandemic},
  journal = {Clinical Drug Investigation},
  year = {2025},
  doi = {10.1007/s40261-025-01444-9}
}
Kostenlos starten →